Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More
SMRUTHI ORGANICS ADCOCK INGRAM |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
SMRUTHI ORGANICS Mar-23 |
ADCOCK INGRAM Jun-14 |
SMRUTHI ORGANICS/ ADCOCK INGRAM |
5-Yr Chart Click to enlarge
|
||
High | Rs | 279 | 322 | - | |
Low | Rs | 111 | 232 | - | |
Sales per share (Unadj.) | Rs | 123.2 | 95.8 | - | |
Earnings per share (Unadj.) | Rs | 3.6 | -24.1 | - | |
Cash flow per share (Unadj.) | Rs | 7.6 | -20.0 | - | |
Dividends per share (Unadj.) | Rs | 2.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 59.5 | 75.2 | - | |
Shares outstanding (eoy) | m | 11.45 | 168.78 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.6 | 2.9 | 54.6% | |
Avg P/E ratio | x | 54.0 | -11.5 | -469.9% | |
P/CF ratio (eoy) | x | 25.6 | -13.9 | -184.8% | |
Price / Book Value ratio | x | 3.3 | 3.7 | 88.7% | |
Dividend payout | % | 55.4 | 0 | - | |
Avg Mkt Cap | Rs m | 2,229 | 46,762 | 4.8% | |
No. of employees | `000 | NA | 4.3 | 0.0% | |
Total wages/salary | Rs m | 158 | 2,935 | 5.4% | |
Avg. sales/employee | Rs Th | 0 | 3,764.6 | - | |
Avg. wages/employee | Rs Th | 0 | 683.6 | - | |
Avg. net profit/employee | Rs Th | 0 | -948.6 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 1,410 | 16,162 | 8.7% | |
Other income | Rs m | 1 | 113 | 0.9% | |
Total revenues | Rs m | 1,411 | 16,275 | 8.7% | |
Gross profit | Rs m | 98 | -2,801 | -3.5% | |
Depreciation | Rs m | 46 | 698 | 6.6% | |
Interest | Rs m | 8 | 438 | 1.9% | |
Profit before tax | Rs m | 45 | -3,823 | -1.2% | |
Minority Interest | Rs m | 0 | -11 | -0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 4 | 239 | 1.5% | |
Profit after tax | Rs m | 41 | -4,072 | -1.0% | |
Gross profit margin | % | 6.9 | -17.3 | -40.0% | |
Effective tax rate | % | 8.1 | -6.2 | -129.2% | |
Net profit margin | % | 2.9 | -25.2 | -11.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 667 | 11,837 | 5.6% | |
Current liabilities | Rs m | 369 | 6,660 | 5.5% | |
Net working cap to sales | % | 21.1 | 32.0 | 66.0% | |
Current ratio | x | 1.8 | 1.8 | 101.8% | |
Inventory Days | Days | 3 | 111 | 3.0% | |
Debtors Days | Days | 957 | 124 | 771.8% | |
Net fixed assets | Rs m | 403 | 6,900 | 5.8% | |
Share capital | Rs m | 114 | 75 | 152.5% | |
Net worth | Rs m | 682 | 12,685 | 5.4% | |
Long term debt | Rs m | 6 | 4,458 | 0.1% | |
Total assets | Rs m | 1,070 | 23,963 | 4.5% | |
Interest coverage | x | 6.5 | -7.7 | -83.5% | |
Debt to equity ratio | x | 0 | 0.4 | 2.4% | |
Sales to assets ratio | x | 1.3 | 0.7 | 195.4% | |
Return on assets | % | 4.6 | -15.2 | -30.5% | |
Return on equity | % | 6.1 | -32.1 | -18.9% | |
Return on capital | % | 7.7 | -19.8 | -39.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 121 | 1,380 | 8.8% | |
From Investments | Rs m | -102 | -424 | 24.2% | |
From Financial Activity | Rs m | -15 | 4,046 | -0.4% | |
Net Cashflow | Rs m | 3 | 5,002 | 0.1% |
Compare SMRUTHI ORGANICS With: ACTAVIS (US) MYLAN (US) TEVA PHARMA (Israel)
Compare SMRUTHI ORGANICS With: ISHITA DRUGS GUFIC BIOSCIENCE ALPA LAB FREDUN PHARMA MANGALAM DRUGS
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended higher.